BridgeBio Pharma - 5 Year Stock Price History | BBIO
Historical daily share price chart and data for BridgeBio Pharma since 2019 adjusted for splits and dividends. The latest closing stock price for BridgeBio Pharma as of December 20, 2024 is 26.49.
- The all-time high BridgeBio Pharma stock closing price was 72.35 on February 08, 2021.
- The BridgeBio Pharma 52-week high stock price is 44.32, which is 67.3% above the current share price.
- The BridgeBio Pharma 52-week low stock price is 21.62, which is 18.4% below the current share price.
- The average BridgeBio Pharma stock price for the last 52 weeks is 28.53.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| BridgeBio Pharma Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
28.3077 |
40.4500 |
40.4500 |
22.3500 |
26.4900 |
-34.38% |
| 2023 |
21.3429 |
7.1700 |
43.8900 |
7.1700 |
40.3700 |
429.79% |
| 2022 |
9.6533 |
17.1600 |
17.1600 |
5.2100 |
7.6200 |
-54.32% |
| 2021 |
54.4717 |
63.6400 |
72.3500 |
11.3800 |
16.6800 |
-76.54% |
| 2020 |
35.3461 |
33.2200 |
71.1100 |
16.1100 |
71.1100 |
102.88% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$4.953B |
$0.009B |
|
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
|
